TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative nucleic acid products to customers across Europe, Middle East, and Africa. This distribution partnership is expected to improve the ordering process and offer shorter lead times for European customers — increasing access to TriLink’s novel nucleic acid technologies
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: